Onset of inflammatory bowel diseases during combined α-interferon and ribavirin therapy for chronic hepatitis C: Report of two cases

Federica Villa, Maria Grazia Rumi, Clementina Signorelli, Simone Saibeni, Ersilio Del Ninno, Stefano Ferrero Bogetto, Roberto De Franchis, Maurizio Vecchi

Research output: Contribution to journalArticlepeer-review

Abstract

We report two patients who developed an inflammatory bowel disease (IBD) shortly after beginning combined α-interferon and ribavirin treatment for HCV-related chronic hepatitis. The previous clinical history was negative for IBD in both patients, who developed diarrhoea and rectal bleeding 10 days and 6 months, respectively, after the initiation of therapy. The history, therapeutic management and the possible causal relationships of these cases are discussed.

Original languageEnglish
Pages (from-to)1243-1245
Number of pages3
JournalEuropean Journal of Gastroenterology and Hepatology
Volume17
Issue number11
DOIs
Publication statusPublished - Nov 2005

Keywords

  • Inflammatory bowel dieases
  • Interferon
  • Ribavirin

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Onset of inflammatory bowel diseases during combined α-interferon and ribavirin therapy for chronic hepatitis C: Report of two cases'. Together they form a unique fingerprint.

Cite this